HackerNoon
Series B Announcements

Ecovia Bio

Summary

Ecovia Bio, a Michigan-based biotechnology spinout, closed a Series B round to expand its manufacturing capacity for sustainable biopolymer ingredients. The funding is targeted at scaling production for its biodegradable gamma polyglutamic acid technology.

Investors

Pointe Angels

Categories

Source

Qubit Capital